Cargando…

Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis

BACKGROUND: In our institute in Marseille, France, we initiated early and massive screening for coronavirus disease 2019 (COVID-19). Hospitalization and early treatment with hydroxychloroquine and azithromycin (HCQ-AZ) was proposed for the positive cases. METHODS: We retrospectively report the clini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lagier, Jean-Christophe, Million, Matthieu, Gautret, Philippe, Colson, Philippe, Cortaredona, Sébastien, Giraud-Gatineau, Audrey, Honoré, Stéphane, Gaubert, Jean-Yves, Fournier, Pierre-Edouard, Tissot-Dupont, Hervé, Chabrière, Eric, Stein, Andreas, Deharo, Jean-Claude, Fenollar, Florence, Rolain, Jean-Marc, Obadia, Yolande, Jacquier, Alexis, La Scola, Bernard, Brouqui, Philippe, Drancourt, Michel, Parola, Philippe, Raoult, Didier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315163/ https://www.ncbi.nlm.nih.gov/pubmed/32593867 http://dx.doi.org/10.1016/j.tmaid.2020.101791

Ejemplares similares

Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
por: Million, Matthieu, et al.
Publicado: (2020)

Outcomes of 2111 COVID-19 Hospitalized Patients Treated with Hydroxychloroquine/Azithromycin and Other Regimens in Marseille, France, 2020: A Monocentric Retrospective Analysis
por: Lagier, Jean-Christophe, et al.
Publicado: (2022)

Rabies Postexposure Prophylaxis, Marseille, France, 1994–2005
por: Gautret, Philippe, et al.
Publicado: (2008)

Rabies Postexposure Prophylaxis for Travelers Injured by Nonhuman Primates, Marseille, France, 2001–2014
por: Blaise, Agathe, et al.
Publicado: (2015)

Life-years lost by COVID-19 patients in public hospitals of Marseille (APHM-South-Eastern France): a limited death toll: a retrospective analysis
por: Arlotto, Sylvie, et al.
Publicado: (2021)

Different pattern of the second outbreak of COVID-19 in Marseille, France
por: Gautret, Philippe, et al.
Publicado: (2021)

WITHDRAWN: Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients
por: Million, Matthieu, et al.
Publicado: (2021)

Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin
por: Million, Matthieu, et al.
Publicado: (2021)

Asymptomatic hypoxia in COVID-19 is associated with poor outcome
por: Brouqui, Philippe, et al.
Publicado: (2021)

Cardiovascular Safety of Hydroxychloroquine–Azithromycin in 424 COVID-19 Patients
por: Million, Matthieu, et al.
Publicado: (2023)

Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot
por: Amrane, Sophie, et al.
Publicado: (2020)

Clinical outcomes in patients infected with different SARS-CoV-2 variants at one hospital during three phases of the COVID-19 epidemic in Marseille, France
por: Hoang, Van-Thuan, et al.
Publicado: (2021)

Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19
por: Castelli, Maxime, et al.
Publicado: (2020)

Correction to: Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19
por: Castelli, Maxime, et al.
Publicado: (2021)

Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
por: Gautret, Philippe, et al.
Publicado: (2020)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
por: Gautret, Philippe, et al.
Publicado: (2020)

Outbreak of pneumococcal pneumonia among shipyard workers in Marseille, France, January to February 2020
por: Cassir, Nadim, et al.
Publicado: (2020)

Introduction of the SARS-CoV-2 Beta variant from Comoros into the Marseille geographical area
por: Hoang, Van Thuan, et al.
Publicado: (2022)

Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults
por: Colson, Philippe, et al.
Publicado: (2020)

Emergence and outcomes of the SARS-CoV-2 ‘Marseille-4’ variant
por: Fournier, Pierre-Edouard, et al.
Publicado: (2021)

SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment
por: Drancourt, Michel, et al.
Publicado: (2021)

Changing Demographics and Prevalence of Body Lice among Homeless Persons, Marseille, France
por: Ly, Tran Duc Anh, et al.
Publicado: (2017)

Analysis of SARS-CoV-2 Variants From 24,181 Patients Exemplifies the Role of Globalization and Zoonosis in Pandemics
por: Colson, Philippe, et al.
Publicado: (2022)

Fever in travelers returning from tropical areas: prospective observational study of 613 cases hospitalised in Marseilles, France, 1999–2003
por: Parola, Philippe, et al.
Publicado: (2006)

Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity
por: Hache, Guillaume, et al.
Publicado: (2021)

Low-dose chest CT for diagnosing and assessing the extent of lung involvement of SARS-CoV-2 pneumonia using a semi quantitative score
por: Leger, Thomas, et al.
Publicado: (2020)

Autochthonous human and animal leptospirosis, Marseille, France
por: Sanchez Fernandez, Pablo, et al.
Publicado: (2020)

Low prevalence of resistance genes in sheltered homeless population in Marseille, France, 2014–2018
por: Ly, Tran Duc Anh, et al.
Publicado: (2019)

Infections in symptomatic travelers returning from the Arabian peninsula to France: A retrospective cross-sectional study
por: Griffiths, Karolina, et al.
Publicado: (2016)

Introduction into the Marseille geographical area of a mild SARS-CoV-2 variant originating from sub-Saharan Africa: An investigational study
por: Colson, Philippe, et al.
Publicado: (2021)

SARS-CoV-2 Vaccination and Protection Against Clinical Disease: A Retrospective Study, Bouches-du-Rhône District, Southern France, 2021
por: Fournier, Pierre-Edouard, et al.
Publicado: (2022)

Observational Cohort Study of Evolving Epidemiologic, Clinical, and Virologic Features of Monkeypox in Southern France
por: Cassir, Nadim, et al.
Publicado: (2022)

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
por: Colson, Philippe, et al.
Publicado: (2020)

Olfactory and gustative disorders for the diagnosis of COVID-19
por: Boudjema, Sophia, et al.
Publicado: (2020)

Likely Correlation between Sources of Information and Acceptability of A/H1N1 Swine-Origin Influenza Virus Vaccine in Marseille, France
por: Nougairède, Antoine, et al.
Publicado: (2010)

Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine?
por: Lagier, Jean Christophe, et al.
Publicado: (2020)

Effect of Media Warnings on Rabies Postexposure Prophylaxis, France
por: Gautret, Philippe, et al.
Publicado: (2011)

Does spitting in public play a role in transmitting SARS-CoV-2?
por: Gautret, Philippe, et al.
Publicado: (2020)

Consequences of the COVID-19 Outbreak Lockdown on Non-Viral Infectious Agents as Reported by a Laboratory-Based Surveillance System at the IHU Méditerranée Infection, Marseille, France
por: Kaba, Lanceï, et al.
Publicado: (2021)

Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France
por: Dao, Thi Loi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3kmmkf7qge2t8cejd004dgf4jc